NORTHEAST GEORGIA MEDICAL'S LEVEL I TRAUMA CENTER ENROLLS 170TH PATIENT FOR PRYTIME MEDICAL'S INTERNATIONAL STUDY
GAINESVILLE, Ga., June 27, 2025 /PRNewswire/ -- When patients arrive at Northeast Georgia Medical Center (NGMC) in Gainesville with traumatic injuries, they're not only receiving the most advanced, expert care – they're helping to improve health care for people around the world. NGMC recently enrolled the 170th patient in the Partial REBOA Outcomes Multicenter ProspecTive (PROMPT) study, which shares data to improve outcomes for those critically injured patients.
A pREBOA-PRO™ catheter was used to control life-threatening bleeding in the 170th patient, who arrived at the hospital's Level I Trauma Center, following a blunt trauma injury. The intervention stabilized the patient, reduced the need for additional blood products and ultimately saved their life.
The trauma team at NGMC Gainesville routinely performs partial aortic occlusion – restricting blood flow through the aorta, the largest artery in the body – using the pREBOA-PRO™ device. As part of the PROMPT study, the team shares data on the use of the device to help advance clinical care.
"When someone experiences a traumatic injury, every second matters," said Michael Cormican, MD, trauma surgeon at NGMC Gainesville. "We are grateful for the opportunity to support research that can lead to better outcomes for trauma patients."
The international PROMPT study, funded by the Department of Defense, aims to ultimately enroll 340 patients across nine selected centers. NGMC patients who meet the study criteria are automatically enrolled. To learn more about NGMC's trauma program, visit nghs.com/trauma.
ABOUT NORTHEAST GEORGIA MEDICAL CENTER
Since 1951, Northeast Georgia Medical Center (NGMC) has been on a mission of improving the health of our community in all we do. With hospitals located in Gainesville, Braselton, Winder and Dahlonega, the four NGMC campuses have a total of more than 750 beds and more than 1,200 medical staff members representing more than 60 specialties. NGMC is part of Northeast Georgia Health System, a non-profit that cares for more than one million people across more than 19 counties. Learn more at www.nghs.com.
ABOUT PRYTIME MEDICAL, INC.
The pREBOA-PRO™ device is a product of Prytime Medical Inc, a leading innovator and global provider of lifesaving endovascular occlusion products. Prytime was selected by the U.S. Army Medical Research and Development Command to receive nearly $6 million from the U.S. Department of Defense awarded through the Medical Technology Enterprise Consortium.
ABOUT U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
The U.S. Army Medical Research and Development Command is the Army's medical materiel developer, with responsibility for medical research, development, and acquisition. USAMRDC produces medical solutions for the battlefield with a focus on various areas of biomedical research, including military infectious diseases, combat casualty care, military operational medicine, medical chemical and biological defense. https://mrdc.amedd.army.mil/
ABOUT MTEC
The Medical Technology Enterprise Consortium is a 501(c)(3) biomedical technology consortium that is internationally-dispersed, collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement with the U.S. Army Medical Research and Development Command. The consortium focuses on the development of medical solutions that protect, treat, and optimize the health and performance of U.S. military personnel and civilians. To find out more about MTEC, visit mtec-sc.org.
Disclaimer: The views and conclusions contained herein are those of the authors and should not be interpreted as representing the official policies or endorsements, either expressed or implied, of U.S. Government.
CONTACT: Courtney Randolph, Public Relations & Marketing
Northeast Georgia Medical Center
743 Spring Street NE, Gainesville, GA 30501
770-219-3840 | www.nghs.com
SOURCE Prytime Medical
Share this article